Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024)

Experimental and clinical tests of FDA-approved kinase inhibitors for the treatment of neurological disorders (update 2024)

Since our previous summary of the 74 FDA-approved kinase inhibitors in clinical and preclinical trials for non-cancerous neurological treatment, the US FDA has approved 13 additional kinase inhibitors since early 2022. This update incorporates new evidence for the now 87 FDA-approved kinase inhibito...

Full description

Saved in:
Bibliographic Details
Main Authors: Hassan Aliashrafzadeh, Dewey Liu, Samantha De Alba, Imad Akbar, Austin Lui, Jordan Vanleuven, Ryan Martin, Zhang Wang, Da Zhi Liu
Format: Article
Language:English
Published: Open Exploration 2025-07-01
Series:Exploration of Drug Science
Subjects:
kinase inhibitors
aberrant cell cycle
clinical trials
preclinical experiments
neurological disorders
Online Access:https://www.explorationpub.com/uploads/Article/A1008116/1008116.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.explorationpub.com/uploads/Article/A1008116/1008116.pdf

Similar Items